These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23682480)

  • 1. [Castration in the treatment of locally advanced or metastatic prostate cancer].
    Mongiat-Artus P
    Rev Prat; 2013 Apr; 63(4):509-10. PubMed ID: 23682480
    [No Abstract]   [Full Text] [Related]  

  • 2. Reasons for delay of endocrine treatment in cancer of the prostate (until symptomatic metastases occur).
    Christensen MM; Aagaard J; Madsen PO
    Prog Clin Biol Res; 1990; 359():7-14; discussion 15-24. PubMed ID: 2284298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate.
    Robinson MR
    Prog Clin Biol Res; 1987; 243A():383-90. PubMed ID: 2958863
    [No Abstract]   [Full Text] [Related]  

  • 4. Carcinoma of the prostate: reasons for endocrine treatment prior to symptomatic metastases.
    Chisholm GD
    Prog Clin Biol Res; 1990; 359():1-6; discussion 15-24. PubMed ID: 2284285
    [No Abstract]   [Full Text] [Related]  

  • 5. Current management of prostatic carcinoma.
    Bahnson RR; Catalona WJ
    Prim Care; 1985 Dec; 12(4):795-813. PubMed ID: 3909178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The questionable use of hormone therapy in advanced carcinoma of the prostate.
    Murphy GP; Slack NH
    Urol Clin North Am; 1980 Oct; 7(3):631-8. PubMed ID: 6161459
    [No Abstract]   [Full Text] [Related]  

  • 7. Bilateral orchiectomy in the management of stage D-2 prostate cancer.
    Guinan P; Firfer R; Targonski P; Rubenstein M
    Int Surg; 1993; 78(1):73-5. PubMed ID: 8473090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy.
    Mayer FJ; Crawford ED
    Urol Clin North Am; 1994 Nov; 21(4):707-15. PubMed ID: 7974899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconsideration of orchiectomy in the treatment of advanced prostatic carcinoma.
    Jordan WP; Blackard CE; Byar DP
    South Med J; 1977 Dec; 70(12):1411-3. PubMed ID: 594790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of newly diagnosed metastatic carcinoma of the prostate.
    Elder JS; Catalona WJ
    Urol Clin North Am; 1984 May; 11(2):283-95. PubMed ID: 6428022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [How to treat locally advanced and metastatic untreated cancer of the prostate?].
    Khoury S
    Prog Urol; 1996 Apr; 6(2 Suppl 1):42-5. PubMed ID: 8704744
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of diethylstilbestrol or orchiectomy with buserelin and with methotrexate plus diethylstilbestrol or orchiectomy in newly diagnosed patients with clinical stage D2 cancer of the prostate.
    Huben RP; Murphy GP
    Cancer; 1988 Nov; 62(9):1881-7. PubMed ID: 3139279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment results of combined hormone and chemotherapy in patients with advanced prostate cancer].
    Uekado Y
    Hinyokika Kiyo; 1991 Aug; 37(8):825-31. PubMed ID: 1957724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The case for early combined hormonal and cytostatic treatment for metastatic prostatic carcinoma.
    Servadio C
    Prog Clin Biol Res; 1987; 243B():449-53. PubMed ID: 3659039
    [No Abstract]   [Full Text] [Related]  

  • 15. Population based study of hormonal therapy and survival in men with metastatic prostate cancer.
    Lu-Yao G; Moore DF; Oleynick JU; DiPaola RS; Yao SL
    J Urol; 2007 Feb; 177(2):535-9. PubMed ID: 17222628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orchiectomy for advanced prostatic carcinoma. A reevaluation.
    Blackard CE; Byar DP; Jordan WP
    Urology; 1973 Jun; 1(6):553-60. PubMed ID: 4588820
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnostics and therapy of the carcinoma of the prostate (author's transl)].
    Schnorr D; Guddat HM; Neuser D; Correns HJ; Dörner G; Mau S
    Zentralbl Chir; 1979; 104(7):436-45. PubMed ID: 112805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Olav Erich Yri, Trine Bjoro and Sophie D. Fossa. Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer. Eur Urol 2006;49:54-58.
    Pitts WR
    Eur Urol; 2007 Mar; 51(3):864. PubMed ID: 16860461
    [No Abstract]   [Full Text] [Related]  

  • 19. [Medical castration in the treatment of locally advanced or metastatic prostate cancer: an update].
    Drouin SJ; Rouprêt M; Davin JL; Soulié M
    Prog Urol; 2009 Apr; 19 Suppl 1():S15-9. PubMed ID: 19465332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early versus delayed endocrine treatment in metastatic prostatic cancer.
    Schröder FH
    Prog Clin Biol Res; 1989; 303():253-60. PubMed ID: 2674988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.